Preservation of Beta Cell Function in Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)
Phase of Trial: Phase IV
Latest Information Update: 11 Aug 2017
At a glance
- Drugs Dapagliflozin (Primary) ; Metformin (Primary) ; Pioglitazone (Primary) ; Saxagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- 07 Aug 2017 Planned End Date changed from 1 Jul 2017 to 1 Jul 2020.
- 07 Aug 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Jul 2020.
- 10 Jun 2017 Biomarkers information updated